Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schiff

Showing results (31-40 of 305) with videos related to

Pageof 31
Sort By:
Oncotarget|July 1, 2021
A new class of radiosensitizers for glioblastomaRoger Abounader, David Schiff
Current Treatment Options in Oncology|May 11, 2019
Multimodality Therapy of Patients with Refractory MeningiomasHaroon Ahmad, David Schiff
Handbook of Clinical Neurology|January 9, 2018
Epidural and intramedullary spinal metastasis: clinical features and role of fractionated radiotherapyDirk Rades, David Schiff
Neurosurgical Focus|July 5, 2007
Chemotherapy and cerebral metastases: misperception or reality?Robert Cavaliere, David Schiff
Nature Reviews. Neurology|July 15, 2009
Advances in the genetics of glioblastoma: are we reaching critical mass?Benjamin Purow, David Schiff
Current Treatment Options in Oncology|August 21, 2014
Therapeutic decision making in patients with newly diagnosed low grade gliomaAdesh Tandon, David Schiff
Nature Clinical Practice. Oncology|February 21, 2008
Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiformeDavid Schiff, Benjamin Purow
Current Neurology and Neuroscience Reports|July 1, 2020
Neurological and Medical Complications in Brain Tumor PatientsDavid Schiff, Mossaed Alyahya
Expert Review of Anticancer Therapy|May 19, 2009
Unmet needs in the treatment of glioblastomaMelike Mut, David Schiff
Neurosurgery|August 16, 2012
CommentsRandy Jensen, David Schiff
Pageof 31

Showing results (31-40 of 305) with videos related to

Sort By:
Pageof 31
Oncotarget|July 1, 2021
A new class of radiosensitizers for glioblastomaRoger Abounader, David Schiff
Current Treatment Options in Oncology|May 11, 2019
Multimodality Therapy of Patients with Refractory MeningiomasHaroon Ahmad, David Schiff
Handbook of Clinical Neurology|January 9, 2018
Epidural and intramedullary spinal metastasis: clinical features and role of fractionated radiotherapyDirk Rades, David Schiff
Neurosurgical Focus|July 5, 2007
Chemotherapy and cerebral metastases: misperception or reality?Robert Cavaliere, David Schiff
Nature Reviews. Neurology|July 15, 2009
Advances in the genetics of glioblastoma: are we reaching critical mass?Benjamin Purow, David Schiff
Current Treatment Options in Oncology|August 21, 2014
Therapeutic decision making in patients with newly diagnosed low grade gliomaAdesh Tandon, David Schiff
Nature Clinical Practice. Oncology|February 21, 2008
Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiformeDavid Schiff, Benjamin Purow
Current Neurology and Neuroscience Reports|July 1, 2020
Neurological and Medical Complications in Brain Tumor PatientsDavid Schiff, Mossaed Alyahya
Expert Review of Anticancer Therapy|May 19, 2009
Unmet needs in the treatment of glioblastomaMelike Mut, David Schiff
Neurosurgery|August 16, 2012
CommentsRandy Jensen, David Schiff
Pageof 31